Prior studies have demonstrated the prognostic and functional significance of MARK3 in various cancers, including breast, ovarian, colorectal, and cervical cancers [12,13,14], but its role in endometrial cancer has remained unexplored until now. Here, MARK3 is linked to cervical carcinoma.